| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 254.604 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 195.356 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 172.175 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 233.763 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 223.821 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 187.657 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 189.023 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 215.562 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 245.206 | 86 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 223.763 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 200.883 | 84 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 258.874 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 217.45 | 84 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 201.997 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 220.921 | 85 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 206.851 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 203.307 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 230.882 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 167.779 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 168.346 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 239.104 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 182.23 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 221.625 | 85 |